These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1280 related articles for article (PubMed ID: 22982887)

  • 1. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
    Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
    Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma.
    Arbajian E; Puls F; Magnusson L; Thway K; Fisher C; Sumathi VP; Tayebwa J; Nord KH; Kindblom LG; Mertens F
    Am J Surg Pathol; 2014 Jun; 38(6):801-8. PubMed ID: 24441665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.
    Doyle LA; Möller E; Dal Cin P; Fletcher CD; Mertens F; Hornick JL
    Am J Surg Pathol; 2011 May; 35(5):733-41. PubMed ID: 21415703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases.
    Prieto-Granada C; Zhang L; Chen HW; Sung YS; Agaram NP; Jungbluth AA; Antonescu CR
    Genes Chromosomes Cancer; 2015 Jan; 54(1):28-38. PubMed ID: 25231134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group.
    Guillou L; Benhattar J; Gengler C; Gallagher G; Ranchère-Vince D; Collin F; Terrier P; Terrier-Lacombe MJ; Leroux A; Marquès B; Aubain Somerhausen Nde S; Keslair F; Pedeutour F; Coindre JM
    Am J Surg Pathol; 2007 Sep; 31(9):1387-402. PubMed ID: 17721195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma.
    Kao YC; Lee JC; Zhang L; Sung YS; Swanson D; Hsieh TH; Liu YR; Agaram NP; Huang HY; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2020 Mar; 44(3):368-377. PubMed ID: 31592798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-grade fibromyxoid sarcoma: Clinical, morphologic and genetic features.
    Mohamed M; Fisher C; Thway K
    Ann Diagn Pathol; 2017 Jun; 28():60-67. PubMed ID: 28648941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerosing epithelioid fibrosarcoma.
    Patterson JW; Tchernev G; Chokoeva AA; Wick MR
    Wien Med Wochenschr; 2017 Apr; 167(5-6):120-123. PubMed ID: 27631873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Renal Hybrid Low-grade Fibromyxoid Sarcoma-Sclerosing Epithelioid Fibrosarcoma: An Unusual Pediatric Case With EWSR1-CREB3L1 Fusion.
    Mok Y; Pang YH; Sanjeev JS; Kuick CH; Chang KT
    Pediatr Dev Pathol; 2018; 21(6):574-579. PubMed ID: 29426275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma.
    Panagopoulos I; Storlazzi CT; Fletcher CD; Fletcher JA; Nascimento A; Domanski HA; Wejde J; Brosjö O; Rydholm A; Isaksson M; Mandahl N; Mertens F
    Genes Chromosomes Cancer; 2004 Jul; 40(3):218-28. PubMed ID: 15139001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma.
    Puls F; Agaimy A; Flucke U; Mentzel T; Sumathi VP; Ploegmakers M; Stoehr R; Kindblom LG; Hansson M; Sydow S; Arbajian E; Mertens F
    Am J Surg Pathol; 2020 May; 44(5):594-606. PubMed ID: 31913156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerosing epithelioid fibrosarcoma - a report of two cases with cytogenetic analysis of FUS gene rearrangement by FISH technique.
    Rekhi B; Folpe AL; Deshmukh M; Jambhekar NA
    Pathol Oncol Res; 2011 Mar; 17(1):145-8. PubMed ID: 20499220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerosing Epithelioid Fibrosarcoma: A Distinct Sarcoma With Aggressive Features.
    Warmke LM; Meis JM
    Am J Surg Pathol; 2021 Mar; 45(3):317-328. PubMed ID: 32769431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-depth Genetic Analysis of Sclerosing Epithelioid Fibrosarcoma Reveals Recurrent Genomic Alterations and Potential Treatment Targets.
    Arbajian E; Puls F; Antonescu CR; Amary F; Sciot R; Debiec-Rychter M; Sumathi VP; Järås M; Magnusson L; Nilsson J; Hofvander J; Mertens F
    Clin Cancer Res; 2017 Dec; 23(23):7426-7434. PubMed ID: 28939748
    [No Abstract]   [Full Text] [Related]  

  • 15. Sclerosing epithelioid fibrosarcoma: cytogenetic analysis of FUS rearrangement.
    Yoon N; Kwon JW; Seo SW; Ahn G; Choi YL
    Pathol Int; 2012 Jan; 62(1):65-8. PubMed ID: 22192807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FUS (16p11) gene rearrangement as detected by fluorescence in-situ hybridization in cutaneous low-grade fibromyxoid sarcoma: a potential diagnostic tool.
    Patel RM; Downs-Kelly E; Dandekar MN; Fanburg-Smith JC; Billings SD; Tubbs RR; Goldblum JR
    Am J Dermatopathol; 2011 Apr; 33(2):140-3. PubMed ID: 21399449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary sclerosing epithelioid fibrosarcoma of the spine: a single-institution experience.
    Righi A; Pacheco M; Pipola V; Gambarotti M; Benini S; Sbaraglia M; Frisoni T; Boriani S; Dei Tos AP; Gasbarrini A
    Histopathology; 2021 Jun; 78(7):976-986. PubMed ID: 33428796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sclerosing epithelioid fibrosarcoma of the kidney: clinicopathologic and molecular study of a rare neoplasm at a novel location.
    Ohlmann CH; Brecht IB; Junker K; van der Zee JA; Nistor A; Bohle RM; Stöckle M; Metzler M; Hartmann A; Agaimy A
    Ann Diagn Pathol; 2015 Aug; 19(4):221-5. PubMed ID: 25990776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DOG1 Expression in Low-Grade Fibromyxoid Sarcoma: A Study of 11 Cases, With Molecular Characterization.
    Thway K; Ng W; Benson C; Chapman J; Fisher C
    Int J Surg Pathol; 2015 Sep; 23(6):454-60. PubMed ID: 26135531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sclerosing Epithelioid Fibrosarcoma.
    Warmke LM; Yu W; Meis JM
    Surg Pathol Clin; 2024 Mar; 17(1):119-139. PubMed ID: 38278601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.